The global Needle-Free Drug Delivery Devices market size is expected to be worth around US$ 26.27 billion by 2030, according to a new report by Vision Research Reports.
The global Needle-Free Drug Delivery Devices market size was valued at US$ 8.37 billion in 2020 and is anticipated to grow at a CAGR of 20.5% during forecast period 2021 to 2030.
Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.
Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.
The transdermal patch has gained popularity over the years owing to associated advantages such as maintaining constant drug levels, fewer side effects, and effective absorption of medications, which couldn’t be absorbed via GI tract. Additionally, as the substance is released evenly and directly into the bloodstream, less amount of medicine is required. Owing to the aforementioned factors, the segment is anticipated to register the highest growth during the forecast period are anticipated to boost the demand for transdermal patches in coming years.
jet injectors accounted for the largest share in the market, due to benefits associated with them over other traditional drug transportation devices with needles. These benefits include faster drug delivery into bloodstream and insulin distribution over a larger area in lower layer of an individual's skin.
Jet injectors are utilized for a wide array of applications owing to their merits such as rapid administration, improved dosing accuracy, faster response rates, and better diffusion into tissues, reduced pain, reduced sharp waste, and easy portability. However, they can also be utilized for potential applications such as local anesthesia, intralesional corticosteroids, Direct palmar (BoNT-ONA, onabotulinum toxin A) BoNT-ONA, intralesional bleomycin, and Intralesional 5-ALA. These factors are projected to help the market remain dominant until 2030.
Insulin delivery was the most prominent application segment in the needle-free drug delivery device market in 2017. The growth of the segment can be to rising incidence of diabetes and increasing shift towards unhealthy lifestyle habits. For instance, according to the Centers for Disease Control and Prevention, about 30.3 million individuals were affected by diabetes globally in 2017, of which 9.4% were U.S. citizens. However, about 23.1 million people were diagnosed and 7.2 million remained undiagnosed.
Moreover, owing to introduction of technologically advanced products such as insulin micropump, insulin pen, insulin spray, inhalable insulin, and other novel jet injectors, the insulin delivery segment is poised to post a lucrative CAGR during the forecast period. For instance, by 2019, Novartis is expected to launch an EpiPen that will cost around $250.0 and is cheaper than other EpiPen products available in the market. Additionally, Zeneno by Crossject is likely to be launched in the coming years and is estimated to have a lower target price.
the pain management segment held a sizeable share in the market owing to mounting cases of medical conditions such as chronic pain, pain disorder, myofascial pain syndrome, arthritis, and migraines. For instance, according to the American Pain Foundation Chronic in 2020, pain affected about 40-50 million Americans per year.
North America accounted for approximately 44.0% of the overall revenue in 2020. High awareness regarding potential benefits of needle-free drug delivery devices has supported the dominance of the region in the global arena. Moreover, presence of well-developed healthcare facilities and extensive R&D expenditure by government organizations and pharmaceutical companies for diabetes and chronic pain management are also contributing to the growth of the market.
Antares Pharma, 3M, and Injex Pharma AG. Some other key players are Verdict Media Limited; Pharmajet; Zonenix; Inovio Pharmaceuticals, Inc.; Valeritas, Inc.; and Penjet.
Transdermal patch technology
Novel needle-free technologies
Insulin delivery for diabetes
Middle East & Africa
The Needle-Free Drug Delivery Devices market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Needle-Free Drug Delivery Devices market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Needle-Free Drug Delivery Devices market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Needle-Free Drug Delivery Devices market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Needle-Free Drug Delivery Devices market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Needle-Free Drug Delivery Devices capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Needle-Free Drug Delivery Devices by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Needle-Free Drug Delivery Devices market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Needle-Free Drug Delivery Devices market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Needle-Free Drug Delivery Devices market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Needle-Free Drug Delivery Devices industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Needle-Free Drug Delivery Devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Needle-Free Drug Delivery Devices market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Needle-Free Drug Delivery Devices market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Needle-Free Drug Delivery Devices market. These factors have benefited the growth of the global market for Needle-Free Drug Delivery Devices. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Needle-Free Drug Delivery Devices. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Needle-Free Drug Delivery Devices are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Glioblastoma Multiforme Treatment Market (By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy; By Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Others; By End-use: Hospitals, Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
High Pressure Contrast Media Injectors Market (By Product: Injector Systems, Consumables; By Type: Single head injectors, Dual head injectors, Syringeless injectors; By Application: Interventional cardiology, Interventional radiology, Endovascular surgery, Interventional neuroradiology; By End-use: Hospitals, Diagnostic, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Veterinary Antimicrobial Susceptibility Testing Market (By Animal Type: Livestock Animals, Companion Animals; By Product: Disks & Plates, Culture Media, Accessories & Consumables, Automated AST Instruments; By End-use: Veterinary Reference Lab, Veterinary Research Institutes, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Tendonitis Treatment Market (By Treatment: Therapy, Surgery; By Condition: Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Swimmer’s Shoulder, Achilles Tendonitis) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Infectious Disease Molecular Diagnostics Market (By Product: Instruments, Reagents, Services; By End-use: Hospitals, Clinics, Diagnostics Laboratories, Research Institutes; By Technology: Polymerase chain reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...